Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.

Kurolap A, Eshach Adiv O, Hershkovitz T, Tabib A, Karbian N, Paperna T, Mory A, Vachyan A, Slijper N, Steinberg R, Zohar Y, Mevorach D, Baris Feldman H.

J Pediatr Gastroenterol Nutr. 2018 Nov 8. doi: 10.1097/MPG.0000000000002198. [Epub ahead of print]

PMID:
30418410
2.

Prothrombotic mechanisms in patients with congenital p.Cys89Tyr mutation in CD59.

Tabib A, Hindi I, Karbian N, Zelig O, Falach B, Mevorach D.

Thromb Res. 2018 Aug;168:67-77. doi: 10.1016/j.thromres.2018.06.006. Epub 2018 Jun 11.

PMID:
29929138
3.

[TO BE A RESIDENT IN THE DEPARTMENT OF MEDICINE].

Fischer M, Abu Ghosh Z, Rubin L, Kharouf F, Ayalon O, Dror D, Falah B, Mevorach D.

Harefuah. 2018 Mar;157(3):192-196. Hebrew.

PMID:
29582953
4.

[THE NEW HADASSAH-HEBREW UNIVERSITY MEDICAL CENTER: A LEADER IN ISRAELI PUBLIC MEDICINE].

Mevorach D, Leibergall M, Rothstein Z.

Harefuah. 2018 Mar;157(3):142-144. Hebrew.

PMID:
29582941
5.

Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells.

Trahtemberg U, Mevorach D.

Front Immunol. 2017 Oct 25;8:1356. doi: 10.3389/fimmu.2017.01356. eCollection 2017. Review.

6.

Loss of CD55 in Eculizumab-Responsive Protein-Losing Enteropathy.

Kurolap A, Eshach-Adiv O, Hershkovitz T, Paperna T, Mory A, Oz-Levi D, Zohar Y, Mandel H, Chezar J, Azoulay D, Peleg S, Half EE, Yahalom V, Finkel L, Weissbrod O, Geiger D, Tabib A, Shaoul R, Magen D, Bonstein L, Mevorach D, Baris HN.

N Engl J Med. 2017 Jul 6;377(1):87-89. doi: 10.1056/NEJMc1707173. Epub 2017 Jun 28. No abstract available.

7.

Demyelination, strokes, and eculizumab: Lessons from the congenital CD59 gene mutations.

Tabib A, Karbian N, Mevorach D.

Mol Immunol. 2017 Sep;89:69-72. doi: 10.1016/j.molimm.2017.05.024. Epub 2017 Jun 13. Review.

PMID:
28622911
8.

Identification and Characterization of Two Human Monocyte-Derived Dendritic Cell Subpopulations with Different Functions in Dying Cell Clearance and Different Patterns of Cell Death.

Trahtemberg U, Grau A, Tabib A, Atallah M, Krispin A, Mevorach D.

PLoS One. 2016 Sep 30;11(9):e0162984. doi: 10.1371/journal.pone.0162984. eCollection 2016.

9.

Medical education in Israel 2016: five medical schools in a period of transition.

Reis S, Urkin J, Nave R, Ber R, Ziv A, Karnieli-Miller O, Meitar D, Gilbey P, Mevorach D.

Isr J Health Policy Res. 2016 Sep 15;5:45. doi: 10.1186/s13584-016-0104-5. eCollection 2016.

10.

Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.

Mevorach D, Reiner I, Grau A, Ilan U, Berkun Y, Ta-Shma A, Elpeleg O, Shorer Z, Edvardson S, Tabib A.

Ann Neurol. 2016 Nov;80(5):708-717. doi: 10.1002/ana.24770. Epub 2016 Sep 19.

PMID:
27568864
11.

Devastating recurrent brain ischemic infarctions and retinal disease in pediatric patients with CD59 deficiency.

Ben-Zeev B, Tabib A, Nissenkorn A, Garti BZ, Gomori JM, Nass D, Goldshmidt H, Fellig Y, Anikster Y, Nevo Y, Elpeleg O, Mevorach D.

Eur J Paediatr Neurol. 2015 Nov;19(6):688-93. doi: 10.1016/j.ejpn.2015.07.001. Epub 2015 Jul 20.

PMID:
26233519
12.

Apoptotic cells induce NF-κB and inflammasome negative signaling.

Grau A, Tabib A, Grau I, Reiner I, Mevorach D.

PLoS One. 2015 Mar 30;10(3):e0122440. doi: 10.1371/journal.pone.0122440. eCollection 2015.

13.

Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.

Mevorach D.

Mol Immunol. 2015 Sep;67(1):51-5. doi: 10.1016/j.molimm.2015.03.005. Epub 2015 Mar 26. Review.

PMID:
25818314
14.

Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O.

Immunity. 2015 Feb 17;42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. Epub 2015 Feb 10.

15.

Calcium-sensing receptor sequencing in 21 patients with idiopathic or familial parathyroid disorder: pitfalls and characterization of a novel I32 V loss-of-function mutation.

Szalat A, Shahar M, Shpitzen S, Nachmias B, Munter G, Gillis D, Durst R, Mevorach D, Leitersdorf E, Meiner V, Rosen H.

Endocrine. 2015 Mar;48(2):444-53. doi: 10.1007/s12020-014-0370-3. Epub 2014 Aug 5.

PMID:
25091521
16.

[Guidelines for the diagnosis and treatment of the fibromyalgia syndrome].

Ablin JN, Amital H, Ehrenfeld M, Aloush V, Elkayam O, Langevitz P, Mevorach D, Mader R, Sachar T, Amital D, Buskila D; Israeli Rheumatology Association.

Harefuah. 2013 Dec;152(12):742-7, 751, 750. Hebrew.

PMID:
24483001
17.

Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.

Gur C, Coppenhagen-Glazer S, Rosenberg S, Yamin R, Enk J, Glasner A, Bar-On Y, Fleissig O, Naor R, Abed J, Mevorach D, Granot Z, Bachrach G, Mandelboim O.

Cell Host Microbe. 2013 Dec 11;14(6):664-74. doi: 10.1016/j.chom.2013.11.004.

18.

VPS 45-associated primary infantile myelofibrosis--successful treatment with hematopoietic stem cell transplantation.

Stepensky P, Simanovsky N, Averbuch D, Gross M, Yanir A, Mevorach D, Elpeleg O, Weintraub M.

Pediatr Transplant. 2013 Dec;17(8):820-5. doi: 10.1111/petr.12169.

PMID:
24164830
19.

Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I/IIa clinical trial.

Mevorach D, Zuckerman T, Reiner I, Shimoni A, Samuel S, Nagler A, Rowe JM, Or R.

Biol Blood Marrow Transplant. 2014 Jan;20(1):58-65. doi: 10.1016/j.bbmt.2013.10.010. Epub 2013 Oct 15.

20.

The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy.

Stepensky P, Saada A, Cowan M, Tabib A, Fischer U, Berkun Y, Saleh H, Simanovsky N, Kogot-Levin A, Weintraub M, Ganaiem H, Shaag A, Zenvirt S, Borkhardt A, Elpeleg O, Bryant NJ, Mevorach D.

Blood. 2013 Jun 20;121(25):5078-87. doi: 10.1182/blood-2012-12-475566. Epub 2013 Apr 18.

21.

CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy.

Nevo Y, Ben-Zeev B, Tabib A, Straussberg R, Anikster Y, Shorer Z, Fattal-Valevski A, Ta-Shma A, Aharoni S, Rabie M, Zenvirt S, Goldshmidt H, Fellig Y, Shaag A, Mevorach D, Elpeleg O.

Blood. 2013 Jan 3;121(1):129-35. doi: 10.1182/blood-2012-07-441857. Epub 2012 Nov 13.

22.

Pulmonary hemorrhage in antiphospholipid antibody syndrome.

Scheiman Elazary A, Cohen MJ, Aamar S, Dranitzki Z, Tayer-Shifman O, Mevorach D, Ben-Chetrit E, Naparstek Y.

J Rheumatol. 2012 Aug;39(8):1628-31. doi: 10.3899/jrheum.120205. Epub 2012 Jul 1.

PMID:
22753647
23.

Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice.

Benhamron S, Reiner I, Zcharia E, Atallah M, Grau A, Vlodavsky I, Mevorach D.

PLoS One. 2012;7(5):e35602. doi: 10.1371/journal.pone.0035602. Epub 2012 May 10.

24.

Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway.

Atallah M, Krispin A, Trahtemberg U, Ben-Hamron S, Grau A, Verbovetski I, Mevorach D.

PLoS One. 2012;7(2):e29333. doi: 10.1371/journal.pone.0029333. Epub 2012 Feb 17.

25.

Paradoxical response in ocular bartonellosis.

Zimran E, Shilo S, Florescu T, Dotan S, Balag S, Mevorach D, Shibolet O, Amer R.

J Ophthalmic Inflamm Infect. 2012 Mar;2(1):53-6. doi: 10.1007/s12348-011-0046-6. Epub 2011 Nov 5. No abstract available.

26.

Role of class A human thrombospondins in the clearance of dying cells and tolerance induction.

Tabib A, Krispin A, Mevorach D.

Ann N Y Acad Sci. 2010 Oct;1209:43-8. doi: 10.1111/j.1749-6632.2010.05773.x.

PMID:
20958315
27.

What do we mean when we write "senescence," "apoptosis," "necrosis," or "clearance of dying cells"?

Mevorach D, Trahtemberg U, Krispin A, Attalah M, Zazoun J, Tabib A, Grau A, Verbovetski-Reiner I.

Ann N Y Acad Sci. 2010 Oct;1209:1-9. doi: 10.1111/j.1749-6632.2010.05774.x.

PMID:
20958309
28.

The embryotoxicity of sera from patients with autoimmune diseases on post-implantation rat embryos in culture persists during remission and is not related to oxidative stress.

Ergaz Z, Mevorach D, Goldzweig G, Cohen A, Patlas N, Yaffe P, Blank M, Shoenfeld Y, Ornoy A.

Lupus. 2010 Dec;19(14):1623-31. doi: 10.1177/0961203310377218. Epub 2010 Sep 2.

PMID:
20813798
29.

Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.

Mevorach D.

Apoptosis. 2010 Sep;15(9):1114-23. doi: 10.1007/s10495-010-0530-8. Review.

PMID:
20683667
30.

An antibody profile of systemic lupus erythematosus detected by antigen microarray.

Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR.

Immunology. 2010 Jul;130(3):337-43. doi: 10.1111/j.1365-2567.2010.03245.x. Epub 2010 Feb 26.

31.

iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade.

Amarilyo G, Verbovetski I, Atallah M, Grau A, Wiser G, Gil O, Ben-Neriah Y, Mevorach D.

Eur J Immunol. 2010 Mar;40(3):699-709. doi: 10.1002/eji.200838951.

32.

Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells.

Tabib A, Krispin A, Trahtemberg U, Verbovetski I, Lebendiker M, Danieli T, Mevorach D.

PLoS One. 2009 Aug 31;4(8):e6840. doi: 10.1371/journal.pone.0006840.

33.

Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.

Mevorach D, Elchalal U, Rein AJ.

Curr Opin Rheumatol. 2009 Sep;21(5):478-82. doi: 10.1097/BOR.0b013e32832ed817. Review.

PMID:
19584727
34.

Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.

Rein AJ, Mevorach D, Perles Z, Gavri S, Nadjari M, Nir A, Elchalal U.

Circulation. 2009 Apr 14;119(14):1867-72. doi: 10.1161/CIRCULATIONAHA.108.773143. Epub 2009 Mar 30.

PMID:
19332471
35.

Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus.

Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D.

Eur J Immunol. 2008 Oct;38(10):2896-904. doi: 10.1002/eji.200838342.

36.

Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience.

Hershko AY, Berkun Y, Mevorach D, Rubinow A, Naparstek Y.

Semin Arthritis Rheum. 2008 Oct;38(2):110-5. doi: 10.1016/j.semarthrit.2007.09.007. Epub 2008 Jan 25.

PMID:
18221986
37.

'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells.

Zaguri R, Verbovetski I, Atallah M, Trahtemberg U, Krispin A, Nahari E, Leitersdorf E, Mevorach D.

Clin Exp Immunol. 2007 Sep;149(3):543-52. Epub 2007 Jul 23.

38.

Calcium, leukocyte cell death and the use of annexin V: fatal encounters.

Trahtemberg U, Atallah M, Krispin A, Verbovetski I, Mevorach D.

Apoptosis. 2007 Oct;12(10):1769-80.

PMID:
17578666
39.

Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus.

Uziel Y, Gorodnitski N, Mukamel M, Padeh S, Brik R, Barash J, Mevorach D, Berkun Y, Tauber T, Press J, Harel L, Navon P, Rubenstein M, Naparstek Y, Hashkes PJ; Pediatric Rheumatology Study Group Of Israel @ SLERI.

Lupus. 2007;16(2):142-6.

PMID:
17402372
40.

Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS.

Schwartz N, Shoenfeld Y, Barzilai O, Cervera R, Font J, Blank M, Yacobi S, Patlas N, Cohen A, Mevorach D, Ornoy A.

Lupus. 2007;16(2):110-20.

PMID:
17402367
41.

Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages.

Tassiulas I, Park-Min KH, Hu Y, Kellerman L, Mevorach D, Ivashkiv LB.

Hum Immunol. 2007 Mar;68(3):156-64. Epub 2007 Jan 8.

42.

Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states.

Krispin A, Bledi Y, Atallah M, Trahtemberg U, Verbovetski I, Nahari E, Zelig O, Linial M, Mevorach D.

Blood. 2006 Nov 15;108(10):3580-9. Epub 2006 Aug 1.

43.

Spontaneous rupture of lung echinococcal cyst causing anaphylactic shock and respiratory distress syndrome.

Fanne RA, Khamaisi M, Mevorach D, Leitersdorf E, Berkman N, Laxer U, Maly B.

Thorax. 2006 Jun;61(6):550. No abstract available.

44.

Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.

Benhamron S, Nechushtan H, Verbovetski I, Krispin A, Abboud-Jarrous G, Zcharia E, Edovitsky E, Nahari E, Peretz T, Vlodavsky I, Mevorach D.

J Immunol. 2006 Jun 1;176(11):6417-24.

45.

Clozapine-induced systemic lupus erythematosus.

Rami AF, Barkan D, Mevorach D, Leitersdorf E, Caraco Y.

Ann Pharmacother. 2006 May;40(5):983-5. Epub 2006 May 2.

PMID:
16670363
46.

The UVB-induced gene expression profile of human epidermis in vivo is different from that of cultured keratinocytes.

Enk CD, Jacob-Hirsch J, Gal H, Verbovetski I, Amariglio N, Mevorach D, Ingber A, Givol D, Rechavi G, Hochberg M.

Oncogene. 2006 Apr 27;25(18):2601-14.

PMID:
16434974
47.

Quinidine and procainamide inhibit murine macrophage uptake of apoptotic and necrotic cells: a novel contributing mechanism of drug-induced-lupus.

Ablin J, Verbovetski I, Trahtemberg U, Metzger S, Mevorach D.

Apoptosis. 2005 Oct;10(5):1009-18.

PMID:
16151636
48.

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G, Gazit R, Gonen-Gross T, Hanna J, Nahari E, Porgador A, Honigman A, Plachter B, Mevorach D, Wolf DG, Mandelboim O.

Nat Immunol. 2005 May;6(5):515-23. Epub 2005 Apr 10.

PMID:
15821739
49.

Fetal first-degree heart block, or where to set the confidence limit: comment on the article by Sonesson et al.

Rein AJ, Mevorach D, Perles Z, Shovali A, Elchalal U.

Arthritis Rheum. 2005 Jan;52(1):366; author reply 366-8. No abstract available.

50.

Novel APC-like properties of human NK cells directly regulate T cell activation.

Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O.

J Clin Invest. 2004 Dec;114(11):1612-23. Retraction in: J Clin Invest. 2015 Apr;125(4):1763.

Supplemental Content

Loading ...
Support Center